Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
California Governor Gavin Newsom is seriously considering a 2028 presidential run, but will wait until after the 2026 midterms to make a final decision.
LSU officials in high-level discussions about Brian Kelly's future after 49-25 loss to Texas A&M, with buyout negotiations complicating any separation.
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
California Governor Gavin Newsom is seriously considering a 2028 presidential run, but will wait until after the 2026 midterms to make a final decision.
LSU officials in high-level discussions about Brian Kelly's future after 49-25 loss to Texas A&M, with buyout negotiations complicating any separation.